PenderFund Capital Management »

Cardlytics shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Cardlytics shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Cardlytics

Tip: Access up to 7 years of quarterly data

All positions including Cardlytics held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardlytics by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6M 4.5M 1.24
2024-06-30 $5.7M 4.5M 1.28
2024-03-31 $2.5M 2.0M 1.25

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Equinox Gold Corp Note 4.750%10/1 (Principal)
Revance Therapeutics Note 1.750% 2/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Sangoma Technologies Corp Com New (SANG)
Bandwidth Note 0.500% 4/0 (Principal)
PAR Technology Corporation (PAR)
Abrdn Platinum Etf Trust Physcl Platm Shs (PPLT)
Burford Cap Ord Shs (BUR)
Wstrn Ast Clymr Infltn Lkd Opts & Inc (WIW)
Nuveen Div. Advantage Muni. Fund (NAD)
Beyond Meat Note 3/1 (Principal)
Nuveen Insured Tax-Free Adv Munici (NEA)
Docebo (DCBO)

View all positions for PenderFund Capital Management

Top funds holding Cardlytics

PenderFund Capital Management
Oaktree Capital Management
Whitebox Advisors
Wellington Management Company
Russell Investments
Penn Mutual Asset Management
Context Capital Management
Brown Trout Management

View all funds holding Cardlytics